On Thursday (11), the National Health Surveillance Agency (Anvisa) released the number of requests to register monkeypox diagnostic products. There were five requests and all of them have already started analysis.
ADVERTISING
According to Anvisa, the products were Viasure Monkeypox Virus Real Time PCR Detection Kit, manufactured in Spain by the company CerTest Biotec, and Monkeypox Virus Nucleic Acid Detection Kit, manufactured in China by the company Shanghai BioGerm Medical Technology. The two companies are awaiting evaluation from Anvisa's technical staff.
A third product, registered on August 8, is manufactured in Brazil by the company Eco Diagnóstica, but part of the production takes place in another country. Documentation review is still ongoing.
On Wednesday (10), the Monkeypox Virus Antigen Rapid Test, the first order related to a rapid test for antigen detection, manufactured by the Chinese company Shanghai BioGerm Medical Technology, and the product Monkeypox Molecular Kit (MPXV) Bio-Manguinhos, manufactured in Brazil by the Bio-Manguinhos Institute of Immunobiological Technology, submitted the request.
ADVERTISING
Anvisa explained, in a note, that the priority is “the evaluation of all requests for registration of in vitro diagnostic products that can be used as a resource to combat the monkeypox [monkeypox, in English]”.
This text contains information from Agência Brasil.
Top photo: Agência Brasil
